310 related articles for article (PubMed ID: 11991532)
41. Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry.
Gan BK; Baugh D; Liu RH; Walia AS
J Forensic Sci; 1991 Sep; 36(5):1331-41. PubMed ID: 1955829
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat.
De Martinis BS; Barnes AJ; Scheidweiler KB; Huestis MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):450-8. PubMed ID: 17369000
[TBL] [Abstract][Full Text] [Related]
43. Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry.
Lim HK; Su Z; Foltz RL
Biol Mass Spectrom; 1993 Jul; 22(7):403-11. PubMed ID: 8102882
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous enantiomeric determination of MDMA and its phase I and phase II metabolites in urine by liquid chromatography-tandem mass spectrometry with chiral derivatization.
Nakanishi K; Katagi M; Zaitsu K; Shima N; Kamata H; Miki A; Kato H; Harada K; Tsuchihashi H; Suzuki K
Anal Bioanal Chem; 2012 Nov; 404(8):2427-35. PubMed ID: 23010844
[TBL] [Abstract][Full Text] [Related]
45. Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine.
Clauwaert KM; Van Bocxlaer JF; De Letter EA; Van Calenbergh S; Lambert WE; De Leenheer AP
Clin Chem; 2000 Dec; 46(12):1968-77. PubMed ID: 11106329
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH.
Navarro M; Pichini S; Farré M; Ortuño J; Roset PN; Segura J; de la Torre R
Clin Chem; 2001 Oct; 47(10):1788-95. PubMed ID: 11568088
[TBL] [Abstract][Full Text] [Related]
47. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH
Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722
[TBL] [Abstract][Full Text] [Related]
48. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
[TBL] [Abstract][Full Text] [Related]
49. Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by headspace/solid phase micro-extraction (SPME) and GC/MS.
Centini F; Masti A; Barni Comparini I
Forensic Sci Int; 1996 Dec; 83(3):161-6. PubMed ID: 9032950
[TBL] [Abstract][Full Text] [Related]
50. A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction.
Darracq MA; Thornton SL; Minns AB; Gerona RR
J Psychoactive Drugs; 2016; 48(5):351-354. PubMed ID: 27636207
[TBL] [Abstract][Full Text] [Related]
51. Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.
Rasmussen LB; Olsen KH; Johansen SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 842(2):136-41. PubMed ID: 16797258
[TBL] [Abstract][Full Text] [Related]
52. Sensitive determination of methylenedioxylated amphetamines by liquid chromatography.
Herráez-Hernández R; Campíns-Falcó P; Verdú-Andrés J
Analyst; 2001 May; 126(5):581-6. PubMed ID: 11394297
[TBL] [Abstract][Full Text] [Related]
53. Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans.
Steuer AE; Schmidhauser C; Schmid Y; Rickli A; Liechti ME; Kraemer T
Drug Metab Dispos; 2015 Dec; 43(12):1864-71. PubMed ID: 26395866
[TBL] [Abstract][Full Text] [Related]
54. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid.
Scheidweiler KB; Huestis MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):90-9. PubMed ID: 16580268
[TBL] [Abstract][Full Text] [Related]
55. Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry.
Nordgren HK; Beck O
J Anal Toxicol; 2003; 27(1):15-9. PubMed ID: 12587677
[TBL] [Abstract][Full Text] [Related]
56. Identification of some N-hydroxylated metabolites of (+/-)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry.
Dumasia MC
Xenobiotica; 2003 Oct; 33(10):1013-25. PubMed ID: 14555338
[TBL] [Abstract][Full Text] [Related]
57. Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain.
Mueller M; Peters FT; Ricaurte GA; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):119-24. PubMed ID: 18829400
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
Stout PR; Klette KL; Horn CK
J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
[TBL] [Abstract][Full Text] [Related]
59. Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges.
Romberg RW; Ntamack AG; Blacik LJ; Kazarian CM; Snyder JJ; Welsh ER
J Anal Toxicol; 2011 Jan; 35(1):15-22. PubMed ID: 21219698
[TBL] [Abstract][Full Text] [Related]
60. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.
Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
Biochem Pharmacol; 2012 Jan; 83(1):131-8. PubMed ID: 21983032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
